Literature DB >> 32932250

OVOL1/2: Drivers of Epithelial Differentiation in Development, Disease, and Reprogramming.

Kritika Saxena1, Syamanthak Srikrishnan2, Toni Celia-Terrassa3, Mohit Kumar Jolly4.   

Abstract

OVOL proteins (OVOL1 and OVOL2), vertebrate homologs of Drosophila OVO, are critical regulators of epithelial lineage determination and differentiation during embryonic development in tissues such as kidney, skin, mammary epithelia, and testis. OVOL can inhibit epithelial-mesenchymal transition and/or can promote mesenchymal-epithelial transition. Moreover, they can regulate the stemness of cancer cells, thus playing an important role during cancer cell metastasis. Due to their central role in differentiation and maintenance of epithelial lineage, OVOL overexpression has been shown to be capable of reprogramming fibroblasts to epithelial cells. Here, we review the roles of OVOL-mediated epithelial differentiation across multiple contexts, including embryonic development, cancer progression, and cellular reprogramming.
© 2020 S. Karger AG, Basel.

Entities:  

Keywords:  Epithelial differentiation; Epithelial-mesenchymal transition; Mesenchymal-epithelial transition; OVOL1; OVOL2

Mesh:

Substances:

Year:  2020        PMID: 32932250     DOI: 10.1159/000511383

Source DB:  PubMed          Journal:  Cells Tissues Organs        ISSN: 1422-6405            Impact factor:   2.481


  7 in total

1.  The transcription factor Rreb1 regulates epithelial architecture, invasiveness, and vasculogenesis in early mouse embryos.

Authors:  Sophie M Morgani; Jie Su; Jennifer Nichols; Joan Massagué; Anna-Katerina Hadjantonakis
Journal:  Elife       Date:  2021-04-30       Impact factor: 8.140

2.  Identification and validation of a novel zinc finger protein-related gene-based prognostic model for breast cancer.

Authors:  Min Ye; Liang Li; Donghua Liu; Qiuming Wang; Yunuo Zhang; Jinfeng Zhang
Journal:  PeerJ       Date:  2021-10-18       Impact factor: 2.984

3.  An NF-κB/OVOL2 circuit regulates glucose import and cell survival in non-small cell lung cancer.

Authors:  Rui Zhang; Guo-Jun Geng; Jian-Guang Guo; Yan-Jun Mi; Xiao-Lei Zhu; Ning Li; Hong-Ming Liu; Jun-Feng Lin; Jian-Weng Wang; Guang Zhao; Guan-Zhi Ye; Bo-An Li; Qi-Cong Luo; Jie Jiang
Journal:  Cell Commun Signal       Date:  2022-03-28       Impact factor: 5.712

4.  OVOL1 inhibits breast cancer cell invasion by enhancing the degradation of TGF-β type I receptor.

Authors:  Chuannan Fan; Qian Wang; Gerard van der Zon; Jiang Ren; Cedrick Agaser; Roderick C Slieker; Prasanna Vasudevan Iyengar; Hailiang Mei; Peter Ten Dijke
Journal:  Signal Transduct Target Ther       Date:  2022-04-29

5.  Analysis of immune subtypes across the epithelial-mesenchymal plasticity spectrum.

Authors:  Priyanka Chakraborty; Emily L Chen; Isabelle McMullen; Andrew J Armstrong; Mohit Kumar Jolly; Jason A Somarelli
Journal:  Comput Struct Biotechnol J       Date:  2021-06-17       Impact factor: 7.271

6.  Gene Regulatory Networks of Epidermal and Neural Fate Choice in a Chordate.

Authors:  Anthony Leon; Lucie Subirana; Kevin Magre; Ildefonso Cases; Juan J Tena; Manuel Irimia; Jose Luis Gomez-Skarmeta; Hector Escriva; Stéphanie Bertrand
Journal:  Mol Biol Evol       Date:  2022-04-11       Impact factor: 16.240

7.  Comprehensive Analysis of the Expression, Prognosis, and Biological Significance of OVOLs in Breast Cancer.

Authors:  Jingsheng Chen; Hongjun Tang; Taidong Li; Kangwei Jiang; Haiming Zhong; Yuye Wu; Jiangtao He; Dongbing Li; Mengzhen Li; Xingsheng Cai
Journal:  Int J Gen Med       Date:  2021-07-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.